Human hepatocytes are extensively needed in drug discovery and development. Stem cell-derived hepatocytes are expected to be an improved and continuous model of human liver to study drug candidates. Generation of endoderm-derived hepatocytes from human pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem cells, is a complex, challenging process requiring specific signals from soluble factors and insoluble matrices at each developmental stage. In this study, we used human liver progenitor HepaRG-derived acellular matrix (ACM) as a hepatic progenitor-specific matrix to induce hepatic commitment of hPSC-derived definitive endoderm (DE) cells. The DE cells showed much better attachment to the HepaRG ACM than other matrices tested and then differentiated towards hepatic cells, which expressed hepatocyte-specific makers. We demonstrate that Matrigel overlay induced hepatocyte phenotype and inhibited biliary epithelial differentiation in two hPSC lines studied. In conclusion, our study demonstrates that the HepaRG ACM, a hepatic progenitor-specific matrix, plays an important role in the hepatic differentiation of hPSCs.
Introduction
Human embryonic stem cells (hESCs) [1] and human induced pluripotent stem cells (hiPSCs) [2, 3] have the ability to form all cell types of an adult body; thus they are highly interesting sources of cells for various human cell-based applications in the field of drug research. Hepatocytes are needed in drug discovery and development for prediction of biotransformation pathways, possible drug-drug interactions, and hepatotoxicity of a drug candidate. Differentiation of both hESCs and hiPSCs to hepatocyte-like cells has been studied broadly [4] [5] [6] [7] [8] ; but still the biggest challenge is to obtain mature hepatocyte-like cells [9, 10] . In the majority of the currently used differentiation protocols, stem cell fate is guided towards hepatocyte-like cells solely by a stepwise growth factor treatment. It is, however, known that not only soluble factors but also cell-cell interactions and cell-matrix interactions play an important role in the complex, multistage hepatic cell differentiation process [11] .
Biomaterials mimicking the extracellular matrix (ECM) are ideal for in vitro cell culturing since they provide closely tissue-resembling microenvironments for cultured cells. ECM-mimicking in vitro culture systems can be established by using natural biomaterials, such as decellularized matrix, also called acellular matrix (ACM) [12] and ECM components, and synthetic biomaterials, such as synthetic polymeric hydrogels. Decellularized whole organs are the most natural, simulating scaffolds since tissue microarchitecture and its components such as proteins, glycosaminoglycans, and growth factors can be well maintained [13] . These scaffolds are useful in whole organ engineering [14] , but due to demanding decellularization and repopulation processes using perfusion systems, they are not optimal matrices for in vitro high-throughput drug testing during drug development. In addition, whole organ ACM scaffolds cannot mimic a defined region of a tissue to induce cell type-specific effects.
During embryogenesis, the cells from definitive endoderm (DE) differentiate to a fully functional adult hepatocyte fate under specific matrices and hormonal conditions [15] . To mimic the in vivo differentiation process, in vitro hepatic differentiation most commonly starts from DE cells. The soluble factors used during in vitro hepatic differentiation have been given most of the focus of research efforts because they are available commercially in purified forms and can be easily added into culture media. Contrary, the optimal matrix for in vitro hepatic commitment of the DE cells is poorly understood, partially due to the complexity of matrix and unavailability of specific matrix components. Here we show that human liver progenitor cell-derived ACM supports the attachment of DE cells and their hepatic differentiation.
Materials and methods

Preparation of the ACM
We prepared the ACM from human liver progenitor HepaRG cells. The HepaRG cells [16] were obtained from Biopredic (Saint-Grégoire, France), and they were plated at 26,000 cells/cm 2 density and cultured for two weeks in previously prescribed culture conditions during which the cells are known to differentiate to hepatocyte-like cells and cholangiocyte-like cells through a bipotent progenitor [17, 18] . Decellularization was performed as described earlier [19] with some modifications. The cell monolayer was first washed once with distilled water (Gibco, 15230-089) and then incubated with water for 45 minutes at 37°C. Next, the ACM was washed twice with water to ensure complete removal of the cells, and was used immediately for DE cell differentiation. The complete removal of HepaRG cells from the ACM using this protocol was confirmed by DAPI staining and Filamentous actin staining with Alexa Fluor 594 phalloidin (Invitrogen, A12381, 1:50) (data not shown).
Cell cultures
The hESC lines WA07 and H9 [1] and hiPSC line iPS(IMR90)-4 [3] were purchased from WiCell research institute. H9 cells were genetically modified to H9-GFP cells as described earlier by us [20] .
Stem cells were maintained in standard Matrigel culture system (BD Biosciences, 356230, 0.5 mg per one 6-well plate) in mTeSR™1 medium (STEMCELL™ Technologies, 05850). The medium was changed daily. The WA07 and iPS(IMR90)-4 cells were passaged at a ratio of 1:5 every four days by using Versene 1:5000 (Invitrogen, 15040033). The H9-GFP cells were passaged at a ratio of 1:4-1:6 every four days by using Dispase (STEMCELL™ Technologies, 07923). Prior to cell passaging, differentiated cell areas were removed manually. All the cell cultures were maintained at 37°C in a humid atmosphere with 5% CO2. The WA07, H9-GFP, and iPS(IMR90)-4 cells used in this study were at passages p38, p18(13)-p22 (17) , and p18+39 (14), respectively.
HepaRG cells used as controls in qPCR were cultured for two or four weeks in the conditions described above. In the four-week culture, the medium was supplemented with 2% DMSO during the last two weeks to induce the maturation to hepatocyte-like cells.
Differentiation of the human pluripotent stem cells (hPSCs) to DE cells
Different induction medium compositions were tested to maximize the differentiation efficiency of the hPSCs to DE cells. RPMI-1640 medium (Gibco, 31870-025) was supplemented with four different sets of supplements (Fig. 1A) . The selection of the supplements was based on earlier publications [21, 22] . The media M1, M2, M3, and M4 were tested with the iPS(IMR90)-4 cells, media M2 and M4 with the WA07 cells, and medium M1 with the H9-GFP cells. The DE induction was performed for six days, and the media were renewed daily. The best medium was selected for each cell line for generating DE cells for the subsequent differentiation steps.
Hepatic differentiation of the DE cells
The DE cells were detached by a Cell Dissociation Buffer (Gibco, 13151-014) for 15 minutes at 37˚C
followed by an Accutase cell detachment solution (Millipore, SCR005) for one to two minutes at room temperature. The hPSC-derived DE cells were seeded at a ratio of 1:1 onto the HepaRG-ACM. 
RNA isolation, real-time qPCR, and analysis of the real-time qPCR data
Total RNA was extracted from the H9-GFP cells and their derivatives using a TRIzol reagent (Applied Biosystems) except the primers for OCT4 [3] and HNF3B [21] . All the primers were synthesized by Oligomer Oy (Helsinki, Finland), and their sequences are shown in Table S2 . A standard curve for each gene was generated, and the amplification efficiency was used in calculating the relative quantification of the target gene in comparison to the housekeeping gene with an earlier described mathematical model [23] .
ALB secretion and total protein analysis
The hepatic functions of the derived cells were analyzed by determining the secreted ALB. Cell culture media were collected 24 h after medium renewal and frozen for later analysis. Each collected medium sample was analyzed in duplicate with a Human Albumin ELISA kit (Bethyl Laboratories)
following the manufacturer's instructions. The secreted ALB amount was calculated with a standard curve and normalized with the total cellular protein amount. The cellular protein samples were prepared as follows: cells were lysed with a RIPA buffer (Pierce Biotechnology), and the total protein amount was quantified with a BCA Protein Assay kit (Pierce Biotechnology) according to the manufacturer's instructions.
Results
Characterization of the hPSCs
Before differentiating the hPSCs towards DE cells, we checked their pluripotency.
Immunofluorescence of the key pluripotent markers showed that the WA07 and iPS(IMR90)-4 cells highly expressed the transcription factor OCT4 and the surface marker SSEA-4 and that the H9-GFP cells highly expressed OCT4 (Fig. S1A) . In addit ion, flow cytometry showed that 99.7% of the WA07 cells and 93.5% of the iPS(IMR90)-4 cells were positive for SSEA-4 and that 95.3% of the H9-GFP cells were positive for SSEA-3 (Fig. S1B) . The H9-GFP, WA07, and iPS(IMR90)-4 cells did not express the hepatic differentiation markers AFP and HNF4A (Fig. S2A ).
Differentiation of the hPSCs to DE cells
We first differentiated the H9-GFP cells to DE cells in the medium M1 (Fig. 1A) according to a published protocol [24] . After six days in the medium M1, the cells showed uniform morphology (Fig. 1E ). The majority of the derived cells were positive for the DE markers HNF3B and CXCR-4
( Fig. 2) , and 95.7% of them expressed CXCR-4 ( Fig. 1F) . When using the same medium M1 for the WA07 and iPS(IMR90)-4 cells, a pure cell population with DE morphology was produced already in the first one to two days followed by a massive cell death (Fig. 1B) Fig. 1F) .
Hepatic differentiation of the hPSC-derived DE cells
The DE cells were differentiated towards hepatic cells with a three-step differentiation protocol, namely hepatic commitment, hepatic progenitor expansion, and hepatic maturation (Fig. 3A) . The DE cells were produced in a Matrigel-coated dish where the hPSCs were cultured. As Matrigel may not be an ideal matrix for hepatic commitment of the DE cells, we tested different matrices for the attachment of the hPSC-derived DE cells. Only a few DE cells attached to the standard cell culture dish, Matrigel-coated dish, rat collagen type I-coated dish, and mouse laminin-111-coated dish (Fig.   S3 ), and none attached to human collagen type III-coated dish (data not shown). Therefore, these cultures were stopped after two days. In contrast, the DE cells well attached to the HepaRG-derived ACM (Fig. S3) . We then induced hepatic commitment in this condition using BMP2, BMP4, and FGF4. The H9-GFP, WA07, and iPS(IRM90)-4-derived DE cells formed confluent monolayer on the HepaRG-ACM after four-day treatment (Day 10, Fig. 3B ). The cells showed polygonal-shaped morphology with cytoplasmic vacuoles and pericytoplasmic actin as seen under a phase contrast microscopy and by F-actin staining, respectively ( Fig. 3B and 3C) . Some of the cells were binucleated. These morphological characteristics were previously reported for hESC-derived hepatocytes [6, 25] and were similar to cultured human primary hepatocytes [26] [27] [28] . The H9-GFPderived cells formed homogenous monolayer by day 18 (Fig. 3B) . The expression of hepatic progenitor markers was studied by immunofluorescence. The WA07, iPS(IMR90)-4, and H9-GFPderived progenitors expressed HNF4A and CK-19 proteins (Fig. 4A ), but they were negative for AFP on day 10 (data not shown). The protein expression level seems to vary among the cells in the same culture, particularly in the H9-GFP cells. The WA07-derived cells showed the highest expression level of HNF4A protein among the three cell lines. The AFP protein expression appeared later, on day 13 in the WA07 and iPS(IMR90)-4-derived progenitors and on day 14 in the H9-GFP-derived progenitors (Fig. 4B ).
In the next differentiation steps, the hepatic progenitors were expanded in the presence of HGF, OSM, and DEX, after which hepatic maturation was induced by DEX. Matrigel overlay was tested during the maturation. The expression of hepatic markers was studied at protein level. On day 18, the WA07- Hepatic functions of the H9-GFP-derived cells were investigated by measuring ALB secretion. From day 16 to day 21, the hepatic cells increased their ALB protein production, and on the last time point, the cells secreted 119 ng ALB per mg total cellular proteins per day (Fig. S5) .
Gene expression profiles in the hPSCs and their derivatives during differentiation
We studied the transcriptional profiles of pluripotency and liver specific genes in the three cell lines during the differentiation and also compared the levels with those in the human primary hepatocytes, HepaRG, and HepG2 cells by qPCR. The mRNA expression levels of the pluripotency markers OCT4 (Fig. 6) and NANOG (Fig. S6) in the WA07 and iPS(IMR90)-4-derived cells decreased to the levels similar to those in the human primary hepatocytes and HepaRG cells as shown by qPCR. The mRNA expression of HNF3B (FOXA2), a maker of foregut endoderm [29] , increased about 200-250-fold in the DE cells (day 6) and hepatic progenitor cells (day 10) and then dropped to the level similar to that in the HepaRG cells, which was much lower than that in the human primary hepatocytes (Fig. 6) . The mRNA expression of the liver specific cytokeratins CK-8 and CK-18 increased to the maximal levels at day 12 and then decreased at day 17 in the WA07 and iPS(IMR90)-4-derived cells (Fig. 6 ). In the
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and CK-19 in the final studied time point, which indicates that the cells were not mature hepatocytes yet ( Fig. 6 and S7 ). The expression of the hepatocyte markers ALB and alpha-1 antitrypsin (AAT) was increasing during the culture period confirming the hepatic lineage differentiation, but the expression level was much lower than the levels in the human primary hepatocytes, HepaRG cells, or HepG2 cells ( Fig. 6 and S7 ).
Matrigel overlay greatly increased the mRNA expression of ALB and AAT and slightly decreased the mRNA expression of CK-19 in the WA07-derived hepatic cells compared with the cells without Matrigel overlay, but it did not affect the expression of AFP (Fig. 6A) . On the other hand, the expression of APF, ALB, and AAT in the iPS(IMR90)-4-derived cells was decreased in the presence of Matrigel overlay (Fig. 6B ).
We were interested to know how the markers of hepatic stem cells and hepatoblasts changed during the differentiation. Neural cell adhesion molecule 1 (NCAM1), a marker of hepatic stem cells [30] , was expressed at a very low level in the human primary hepatocytes but at much higher levels in the WA07 and iPS(IMR90)-4-derived hepatic cells and HepaRG cells (Fig. S6) . Intercellular adhesion molecule 1 (ICAM1), a marker of hepatoblasts [30] , was expressed at lower levels in the WA07 and iPS(IMR90)-4-derived hepatic cells than in the human primary hepatocytes and HepaRG cells (Fig.   S6 ).
The mRNA expression of ATP-binding cassette, sub-family B, member 1 (MDR1, ABCB1), one of the important drug transporters, in the H9-GFP cells was increased during the differentiation (Fig.   S7 ), but the level was still lower than those in the HepaRG and HepG2 cells.
We also noticed that HepaRG cells expressed a hepatoblast marker, CK-19, which was slightly increased by the 2-week treatment with 2% DMSO (Fig. 6) . The mRNA expression levels of CK-8
and CK-18 in the 2-week cultured HepaRG cells was similar to that in the undifferentiated stem cells, but was increased by the 2-week treatment with 2% DMSO (Fig. 6 ). This confirms that the HepaRG cells used to produce the ACM were at the progenitor stage.
Discussion
Human PSCs offer a great supply of all types of somatic cells for basic research and biomedical applications, and thus the in vitro differentiation has been extensively studied. Generation of DEderived hepatocytes from hPSCs is a complex, challenging process requiring specific signals from soluble factors and insoluble matrices at each developmental stage. In the present study, we exploited the use of HepaRG-derived ACM in hepatic differentiation of hPSCs and found that the HepaRG-ACM supported the attachment of hPSC-derived DE cells and their differentiation towards hepatic cells.
The role of the ECM in hepatic commitment of DE cells
The ECM is dynamic, and its remodeling is an important mechanism by which cell differentiation and tissue formation are regulated [31, 32] . To induce hepatic commitment, most attention and effort have been paid to the selection of soluble factors, but not to the compositions of matrices. Little is known about the exact matrix environments for DE induction and hepatic commitment. Researchers have used the same matrices for both DE induction of hPSCs and hepatic commitment of DE cells, such as feeder cells [4, 6] or Matrigel [7] , which are used for the culture of hPSCs. We hypothesized [33] . Another study described the finding of integrins αV and β5 on DE cells and suggested that vitronectin would be a suitable matrix [34] . Many integrins can bind to more than one ligand. For example, integrins αV and β5 can bind not only to vitronectin, but also to bone sialoprotein and osteopontin [35] . Cells may express more than one pair of integrins, as described earlier [33] . Thus, studying the expression of integrins makes it less efficient to screen for the optimal matrices. In contrast, our approach was to provide the liver progenitor environment to DE cells in order to induce hepatic commitment. Plating DE cells to a suitable environment also purifies the cell population and removes unwanted cell types. The characterization of the HepaRG-ACM is under investigation in our laboratory, and it will guide us to produce fully synthetic matrix without humanderived components.
Acellular matrices are attractive in vitro culture scaffolds offering close mimics of in vivo cellular microenvironment since the physical structure together with biochemical components can be wellpreserved after decellularization process [36] . Whole livers [36] , liver slices [37] , and cultured liver cells [19] have been used to produce ACM. Decellularized whole organs are suitable in the near future for organ transplantation [38] ; however, the complex decellularization process of whole organs and the variability between organs hinder their use in industrial scales, particularly in drug testing applications. On the other hand, the decellularization of cultured cells can be performed without sophisticated equipment. In addition, cell-derived ACM can exert cell type-specific effect. Cultured cell-derived ACM has been used in directing the differentiation of ESCs to pancreatic cells [39] and the osteogenesis [40] , adipogenesis [41] , and chondrogenesis [42] of mesenchymal stem cells (MSCs). The fetal MSC-derived ACM was shown to enhance the ex vivo expansion of adult MSCs [43] .
DE differentiation conditions vary between hPSC lines
DE-like cells have been generated from hPSCs in feeder-free culture without serum using various combinations of the following components: Activin A [21] , B-27 [22] , Wnt-3a and sodium butyrate [7, 24] , insulin-transferrin-selenium, and albumin [4] . We used different DE induction media for the H9-GFP cells than for the WA07 and iPS(IMR90)-4 cells since we noticed that the media supplemented with Wnt-3a and sodium butyrate reduced cell viability. Thus, the optimization of DE induction step is crucial, and in our experience it is needed for every hPSC line. Although different DE induction media were used, the expression of the DE markers CXCR-4 and HNF3B was increased to a similar extent in all the studied cell lines after six days of induction. We obtained about 82-96%
CXCR-4 positive cells and more than 90% HNF3B positive cells from all three cell lines at this stage.
The reason for such difference in DE induction conditions between cell lines is unknown and is currently under investigation in our laboratory. Sodium butyrate is a known inhibitor of histone deacetylase [44] , and at the concentration of 0.5 mM and above, it can cause cell differentiation followed by cell death [45] . Considerable cell death in the DE induction of hESCs was reported earlier [46] .
Differentiation capacity varies between hPSC lines
In this study, we have found that different hPSC lines responded differently to the hepatic differentiation conditions. Before hepatic differentiation, the DE cells derived from all three cell lines expressed CXCR-4 and HNF3B at similar levels. Immunofluorescence showed that more than 90%
of the DE cells were positive for HNF3B, indicating that the cells from all three cell lines should be competent to commit to hepatic lineage because HNF3B plays a critical role in the initiation of early liver development [29] but is not important in maintenance of liver functions in adult hepatocytes [47] . The variability of hepatic differentiation between hPSC lines has been noted before. An earlier study compared 28 hiPSC lines and found that hiPSCs derived from adult fibroblasts differentiated poorly, which was attributable to donor differences [49] . Variations have also been observed in neural differentiation [50] and endothelial differentiation [51] of different hPSC lines.
Maturation of hPSC-derived hepatic cells remains a challenge
Adult, mature hepatocytes have not so far been generated from hPSCs [9, 10] . The phenotype of hPSC-derived hepatic cells closely resembles a fetal, immature hepatocyte phenotype [9, 10] . All the hepatocyte-like cells derived from hPSCs reported earlier were AFP positive [4, 6, 7, 22, 24, 49] .
Ogawa, et al. successfully decreased the number of AFP positive cells to 34% by using cyclic adenosine monophosphate in aggregate culture [52] . In this study, we attempted to improve hepatic maturation by using several methods. HGF can induce the proliferation of hepatocytes but also their transdifferentiation to biliary epithelia [53, 54] . Therefore, we used HGF during the hepatic expansion step and then removed it from the hepatic maturation step. Additionally, we applied Matrigel overlay in the hepatic maturation step because Matrigel overlay was earlier shown to inhibit biliary epithelial differentiation of primary mature adult hepatocytes and induce a mature hepatocyte phenotype [53] .
In our preliminary tests, we observed cell migration and eventually the formation of ductular structures similar to bile ductules in the presence of HGF in the hepatic maturation step. This phenomenon has also been observed in primary hepatocyte culture [53] . When we omitted HGF and applied Matrigel overlay in the hepatic maturation step, we were able to prevent the formation of the ductular structures. In addition, we found that Matrigel overlay enhanced hepatocyte phenotype, To promote hepatic maturation, the optimal matrices should be used together with soluble factors, which can maintain hepatocyte phenotype and inhibit biliary epithelial differentiation. The knowledge obtained from primary hepatocyte cultures can be utilized in the hepatic maturation step of hPSC differentiation. Various culture systems have been developed to maintain and enhance liver functions of primary hepatocytes. Sandwich culture [55] , 3D scaffolds [56] , and microcapsules [57, 58] have been used successfully to enhance liver functions of primary hepatocytes. In addition, in view of our findings mentioned above and also in view of other findings about the role of ACM in directing stem cell fate, reviewed by Hoshiba, et al [13] , a complete in vitro hepatic maturation may require a specific matrix environment.
Conclusions
The ECM and ECM-mimicking biomaterials have recently been shown to be important in controlling stem cell fate. The ECM is dynamic, and its remodeling is an important mechanism by which cell 
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